These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35153852)

  • 1. Impaired Verbal Memory Recall in Patients With Axonal Degeneration and Serum Glycine-Receptor Autoantibodies-Case Series.
    Hansen N; Bartels C; Stöcker W; Wiltfang J; Fitzner D
    Front Psychiatry; 2021; 12():778684. PubMed ID: 35153852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserved visuoconstruction in patients with Alzheimer's pathology and anti-neural autoantibodies: A case control study.
    Hansen N; Hirschel S; Teegen B; Wiltfang J; Malchow B
    Front Dement; 2022; 1():975851. PubMed ID: 39081477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunctional Learning and Verbal Memory in Patients with Elevated Tau Protein Levels and Serum Recoverin Autoantibodies-Case Series and Review.
    Hansen N; Bartels C; Rentzsch K; Stöcker W; Fitzner D
    Brain Sci; 2021 Dec; 12(1):. PubMed ID: 35053759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.
    Carvajal-González A; Leite MI; Waters P; Woodhall M; Coutinho E; Balint B; Lang B; Pettingill P; Carr A; Sheerin UM; Press R; Press R; Lunn MP; Lim M; Maddison P; Meinck HM; Vandenberghe W; Vincent A
    Brain; 2014 Aug; 137(Pt 8):2178-92. PubMed ID: 24951641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis.
    Hansen N; Hirschel S; Stöcker W; Manig A; Falk HS; Ernst M; Vukovich R; Zerr I; Wiltfang J; Bartels C
    Front Psychiatry; 2020; 11():576. PubMed ID: 32714214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy with corticosteroids in anti-neural autoantibody-associated cognitive impairment: Retrospective case series.
    Hansen N; Hirschel S; Rentzsch K; Wiltfang J; Malchow B; Fitzner D
    Front Aging Neurosci; 2022; 14():856876. PubMed ID: 36238935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Alzheimer's Dementia Associated With Cerebrospinal Fluid Neurochondrin Autoantibodies.
    Hansen N; Malchow B; Teegen B; Wiltfang J; Bartels C
    Front Neurol; 2022; 13():879009. PubMed ID: 35785337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
    Fellgiebel A; Kojro E; Müller MJ; Scheurich A; Schmidt LG; Fahrenholz F
    J Geriatr Psychiatry Neurol; 2009 Mar; 22(1):3-9. PubMed ID: 19073834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinsonian Syndrome with Frontal Lobe Involvement and Anti-Glycine Receptor Antibodies.
    Endres D; Prüss H; Rijntjes M; Schweizer T; Werden R; Nickel K; Meixensberger S; Runge K; Urbach H; Domschke K; Meyer PT; Tebartz van Elst L
    Brain Sci; 2020 Jun; 10(6):. PubMed ID: 32585946
    [No Abstract]   [Full Text] [Related]  

  • 12. Persisting Verbal Memory Encoding and Recall Deficiency after mGluR5 Autoantibody-Mediated Encephalitis.
    Hansen N; Rentzsch K; Hirschel S; Wiltfang J; Schott BH; Malchow B; Bartels C
    Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood Pressure and T-Tau in Spinal Fluid Are Associated With Delayed Recall in Participants With Memory Complaints and Dementia of the Alzheimer's Type.
    Hestad KA; Horndalsveen PO; Engedal K
    Front Aging Neurosci; 2021; 13():652510. PubMed ID: 34776922
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease.
    Meyer A; Handabaka I; Ehrensperger MM; Gschwandtner U; Hatz F; Monsch AU; Stieglitz RD; Fuhr P
    Dement Geriatr Cogn Disord; 2020; 49(2):170-178. PubMed ID: 32634809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament light as a biomarker of axonal degeneration in patients with mild cognitive impairment and Alzheimer's disease.
    Chen Y; Therriault J; Luo J; Ba M; Zhang H; Initiative ADN
    J Integr Neurosci; 2021 Dec; 20(4):861-870. PubMed ID: 34997710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Cerebrospinal Fluid Amyloid-Beta Concentration Is Associated with Poorer Delayed Memory Recall in Women.
    Haapalinna F; Paajanen T; Penttinen J; Kokki H; Kokki M; Koivisto AM; Hartikainen P; Solje E; Hänninen T; Remes AM; Herukka SK
    Dement Geriatr Cogn Dis Extra; 2016; 6(2):303-12. PubMed ID: 27504119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.